| Literature DB >> 26646650 |
Heidi Keller1, Lukas Markus Müller2, Goran Markic3, Thomas Schraner4,5, Christian Johannes Kellenberger6,7, Rotraud Katharina Saurenmann8,9.
Abstract
BACKGROUND: To test clinical findings associated with early temporomandibular joint (TMJ) arthritis in comparison to the current gold standard contrast enhanced magnetic resonance imaging (MRI) in children with juvenile idiopathic arthritis (JIA).Entities:
Mesh:
Year: 2015 PMID: 26646650 PMCID: PMC4673741 DOI: 10.1186/s12969-015-0056-2
Source DB: PubMed Journal: Pediatr Rheumatol Online J ISSN: 1546-0096 Impact factor: 3.054
Patients characteristics
| Patients characteristics | All patients | Patients with TMJ involvement on MRI | Patients without TMJ involvement on MRI |
|---|---|---|---|
| Total no. of patients, n (%) | 76 | 53 (70) | 23 (30) |
| Female, n (%) | 42 (55) | 29 (69) | 13 (31) |
| Oligoarticular, n (%) | 24 (32) | 17 (32) | 7 (30) |
| Enthesitis related arthritis n (%) | 9 (12) | 7 (13) | 2 (9) |
| Oligoarticular extended, n (%) | 11(15) | 7 (13) | 4 (17) |
| Polyarticular RF neg, n (%) | 25 (33) | 19 (36) | 6 (26) |
| Systemic, n (%) | 1 (1) | 1 (2) | 0 (0) |
| PsA, n (%) | 2 (3) | 1 (2) | 1 (4) |
| Unclassified, n (%) | 4 (5) | 1 (2) | 3 (13) |
| Age at diagnosis, median (range), years | 5.5 (1–14.9) | 5.4 (1–19.4) | 6.6 (1.1–14.1) |
| Age at examination, median (range), years | 9.7 (1.9–18.6) | 9.6 (1.9–18.6) | 9.8 (4.8–17.8) |
| Disease duration, median (range), years | 2.4 (0.0–15.7) | 1.9 (0.0–15.4) | 3.5 (0.1–15.7) |
| HLA-B27 positive/tested, n (%) ( | 6 (10) | 4 (10) | 2 (11) |
| ANA positive, n (%) ( | 47 (64) | 33 (62) | 14 (61) |
| Uveitis, n (%) | 11 (15) | 6 (11) | 5 (22) |
| Treatment with systemic disease-modifying drugs, n (%) | 31 (41) | 23 (43) | 8 (35) |
| Infliximab, n (%) | 4 (5) | 4 (10) | 0 (0) |
| Etanercept, n (%) | 1 (1) | 0 (0) | 1 (4) |
| Methotrexate, n (%) | 31 (41) | 23 (43) | 8 (35) |
TMJ involvement on MRI = signs of inflammation (effusion/increased enhancement) and/or deformation
Analysis of MRI deformity vs. MOC, corresponding SDS-values and centiles
| MRI deformity | |||||||
|---|---|---|---|---|---|---|---|
| Factor | Examination method | ANOVA | Bonferroni group comparison | ||||
| p-value | Severity subgroups | p-value | Mean difference (S1 - S2) | CI95 (lower, upper) | |||
| S1 | S2 | ||||||
| Maximal mouth opening capacity | Orthodontic ( | 0 | 1 | 0.467 | 3.0 | −2.1, 8.1 | |
| 0.001* | 0 | 2 | 0.001* | 6.9 | 2.5, 11.1 | ||
| 1 | 2 | 0.378 | 3.8 | −2.2, 9.8 | |||
| Rheumatologic ( | 0 | 1 | 0.076 | 4.7 | −0.3, 9.7 | ||
| 0.002* | 0 | 2 | 0.004* | 6.0 | 1.6, 10.4 | ||
| 1 | 2 | 1.000 | 1.3 | −4.7, 7.4 | |||
| SDS values | Orthodontic ( | 0 | 1 | 0.312 | 0.6 | −0.3, 1.5 | |
| <0.001* | 0 | 2 | <0.001* | 1.6 | 0.8, 2.4 | ||
| 1 | 2 | 0.760 | 1.0 | −0.1, 2.0 | |||
| Rheumatologic ( | 0 | 1 | 0.071 | 0.9 | −0.1, 1.9 | ||
| <0.001* | 0 | 2 | <0.001* | 1.5 | 0.6, 2.3 | ||
| 1 | 2 | 0.769 | 0.5 | −0.6, 1.7 | |||
| Centiles | Orthodontic ( | 0 | 1 | 0.142 | 19.5 | −4.2, 43.3 | |
| <0.001* | 0 | 2 | <0.001* | 42.3 | 22.0, 62.5 | ||
| 1 | 2 | 0.147 | 22.7 | −5.1, 50.5 | |||
| Rheumatologic ( | 0 | 1 | 0.023* | 26.9 | 2.8, 50.9 | ||
| <0.001* | 0 | 2 | <0.001* | 42.5 | 21.4, 63.5 | ||
| 1 | 2 | 0.552 | 15.6 | −12.9, 44.2 | |||
One way Anova with post-hoc Bonferroni test to compare the MRI to the MOC’s and the corresponding SDS-values and centiles. All continuous variables were normally distributed. Mean difference between groups with upper and lower 95 % confidence interval (CI95) is provided
MRI deformity subgroups: 0 = normal, 1 = mild, 2 = severe
*p-value < 0.05
Analysis of MRI enhancement vs. MOC, corresponding SDS-values and centiles
| MRI enhancement | |||||||
|---|---|---|---|---|---|---|---|
| Factor | Examination method | ANOVA | Bonferroni group comparison | ||||
| p-value | Severity subgroups | p-value | Mean difference (S1 - S2) | CI95 (lower, upper) | |||
| S1 | S2 | ||||||
| Maximal mouth opening capacity | Orthodontic ( | 0 | 1 | 1.000 | 1.4 | −2.6, 5.4 | |
| 0.005* | 0 | 2 | 0.005* | 6.6 | 1.7, 11.6 | ||
| 1 | 2 | 0.022* | 5.2 | 0.6, 9.8 | |||
| Rheumatologic ( | 0 | 1 | 1.000 | 0.5 | −3.5, 4.5 | ||
| 0.048* | 0 | 2 | 0.064 | 4.9 | −0.2, −0.4 | ||
| 1 | 2 | 0.081 | 4.4 | −0.4,9.8 | |||
| SDS values | Orthodontic ( | 0 | 1 | 1.000 | <−0.1 | −0.7, 0.7 | |
| <0.001* | 0 | 2 | 0.001* | 1.4 | 0.5, 2.3 | ||
| 1 | 2 | 0.001* | 1.4 | 0.5, 2.2 | |||
| Rheumatologic ( | 0 | 1 | 1.000 | −0.1 | −0.9, 0.7 | ||
| 0.008* | 0 | 2 | 0.027* | 1.1 | <0.1, 2.1 | ||
| 1 | 2 | 0.008* | 1.2 | 0.2, 2.2 | |||
| Centiles | Orthodontic ( | 0 | 1 | 1.000 | −0.3 | −19.6, 19.1 | |
| <0.001* | 0 | 2 | 0.001* | 35.4 | 11.7, 59.1 | ||
| 1 | 2 | 0.001* | 35.7 | 13.3, 58.1 | |||
| Rheumatologic ( | 0 | 1 | 1.000 | −1.7 | −21.9, 18.4 | ||
| 0.002* | 0 | 2 | 0.060 | 33.0 | 8.0, 58.1 | ||
| 1 | 2 | 0.002* | 34.8 | 10.9, 58.6 | |||
One way Anova with post-hoc Bonferroni test to compare the MRI to the MOC’s and the corresponding SDS-values and centiles. All continuous variables were normally distributed. Mean difference between groups with upper and lower 95 % confidence interval (CI95) is provided
MRI enhancement subgroups: 0 = normal, 1 = mild, 2 = severe
*p-value < 0.05
Fig. 1Boxplots of MRI vs. maximal mouth opening capacity. a Deformity vs. maximal mouth opening capacity (orthodontic examination, n = 76). b Enhancement vs. maximal mouth opening capacity (orthodontic examination, n = 76). c Enhancement (excluding patients with deformity) vs. maximal mouth opening capacity (orthodontic examination, n = 51)
Analysis of MRI findings after excluding deformity vs. MOC, corresponding SDS-values and centiles
| MRI enhancement without deformity | |||
|---|---|---|---|
| Factor | Examination method |
| Mean difference (CI95 lower, CI95 upper) |
| Maximal mouth opening capacity | Orthodontic ( | 0.506 | 1.2 (−2.4, 4.7) |
| Rheumatologic ( | 0.719 | −0.7 (−4.4, 3.0) | |
| SDS values | Orthodontic ( | 0.698 | −0.1 (−0.8, 0.5) |
| Rheumatologic ( | 0.265 | −0.4 (−1.2, 0.3) | |
| Centiles | Orthodontic ( | 0.683 | −3.6 (−21.0, 13.9) |
| Rheumatologic ( | 0.270 | −10.5 (−29.5, 8.5) | |
T-test to compare the MRI findings to the MOC’s and the corresponding SDS-values and centiles after excluding patients with deformity. Mean difference between groups with upper and lower 95 % confidence interval (CI95) is provided. All continuous variables were normally distributed
*p-value < 0.05
Analysis of MRI findings vs. clinical parameters
| Pain | Asymmetry | Retrognathia | Restriction in condylar translation | Antegonial notching | Clicking/crepitation | ||||
|---|---|---|---|---|---|---|---|---|---|
| Orthodontic examination | Rheumatological examination | Orthodontic examination | Rheumatological examination | Orthodontic examination | Rheumatological examination | Rheumatological examination | Orthodontic examination | Orthodontic examination | |
| MRI enhancement ( | 0.662 | 0.070 | 0.002* | 0.198 | 0.308 | 0.448 | 0.020* | 0.067 | 0.866 |
| MRI deformation ( | 0.600 | 0.669 | <0.001* | 0.072 | 0.085 | 0.430 | 0.001* | 0.014* | 0.701 |
| MRI enhancement only ( | 0.964 | 0.213 | 0.906 | 0.231 | 0.259 | 0.948 | 0.371 | 0.449 | 0.782 |
Chi-square test to compare the MRI findings to clinical parameters assessed during the orthodontic or rheumatological examination (p-values)
*p-value < 0.05, NS = not significant